Vaxcyte Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Vaxcyte Inc.
- Former names
- SutroVax, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Carlos
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PCVX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001649094
- EIN
- 46-4233385
Board of directors
-
Anne S. Drapeau · DirectorSince 2023
-
Carlos Paya V · DirectorSince 2023
-
Grant Pickering · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Halley E. Gilbert · DirectorSince 2023
-
Heath Lukatch · DirectorSince 2023
-
Jacks Lee · DirectorSince 2023
-
John Furey · DirectorSince 2024
-
John Markels · DirectorSince 2026
-
Michael E. Kamarck · DirectorSince 2023
-
Moncef Slaoui · DirectorSince 2026
-
Olivier Brandicourt · DirectorSince 2025
-
Peter Hirth · DirectorSince 2023
-
Teri Loxam · DirectorSince 2023
Chief executives
Grant Pickering
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 6, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
83.7%
-
97.6%
-
97.8%
Board connections
8 of this board's directors also sit on 10 other boards.
- via John Markels and Moncef Slaoui
- via Peter Hirth
- via Olivier Brandicourt
- via Halley E. Gilbert
- via Olivier Brandicourt
- via Carlos Paya V
- via Halley E. Gilbert
- via Grant Pickering
- via Michael E. Kamarck
- via Carlos Paya V
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $9,085,596
- 50 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 9, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Open-market sale | −1,334 | $59.52 | $79,401 |
| Sep 8, 2026 | Cowan Elvia Officer (SVP, Finance & CAO) | Shares withheld for tax | −1,327 | $60.36 | $80,098 |
| Sep 8, 2026 | Dhaliwal Harpreet S. Officer (Chief Technical Ops Officer) | Shares withheld for tax | −7,651 | $60.36 | $461,814 |
| Sep 8, 2026 | Andrew Guggenhime Officer (PRESIDENT AND CFO) | Shares withheld for tax | −7,155 | $60.36 | $431,876 |
| Sep 8, 2026 | Grant Pickering Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for tax | −17,056 | $60.36 | $1,029,500 |
| Sep 8, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Shares withheld for tax | −5,459 | $60.36 | $329,505 |
| Sep 4, 2026 | Jodar Luis Officer (Chief Medical Officer) | Grant or award | +52,632 | — | — |
| Sep 4, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Open-market sale | −1,381 | $61.16 | $84,462 |
| Sep 2, 2026 | Cowan Elvia Officer (SVP, Finance & CAO) | Shares withheld for tax | −326 | $61.58 | $20,075 |
| Sep 2, 2026 | Dhaliwal Harpreet S. Officer (Chief Technical Ops Officer) | Shares withheld for tax | −659 | $61.58 | $40,581 |
| Sep 2, 2026 | Andrew Guggenhime Officer (PRESIDENT AND CFO) | Shares withheld for tax | −1,432 | $61.58 | $88,183 |
| Sep 2, 2026 | Grant Pickering Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for tax | −3,427 | $61.58 | $211,035 |
| Sep 2, 2026 | Wassil Jim Officer (CHIEF OPERATING OFFICER) | Shares withheld for tax | −1,432 | $61.58 | $88,183 |
| Sep 1, 2026 | Wassil Jim Officer (CHIEF OPERATING OFFICER) | Option exercise | +2,250 | $5.35 | $12,038 |
| Sep 1, 2026 | Wassil Jim Officer (CHIEF OPERATING OFFICER) | Open-market sale | −1,537 | $60.89 | $93,582 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.